These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26711719)

  • 1. The Effect of Exercise with or Without Metformin on Glucose Profiles in Type 2 Diabetes: A Pilot Study.
    Myette-Côté É; Terada T; Boulé NG
    Can J Diabetes; 2016 Apr; 40(2):173-7. PubMed ID: 26711719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is better, high-dose metformin monotherapy or low-dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low-dose metformin monotherapy? A randomized, cross-over, continuous glucose monitoring-based pilot study.
    Takahashi H; Nishimura R; Tsujino D; Utsunomiya K
    J Diabetes Investig; 2019 May; 10(3):714-722. PubMed ID: 30171747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise timing and blood lactate concentrations in individuals with type 2 diabetes.
    Heden TD; Liu Y; Kanaley JA
    Appl Physiol Nutr Metab; 2017 Jul; 42(7):732-737. PubMed ID: 28208021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination.
    Guillausseau PJ
    Diabet Med; 1997 Sep; 14(9):798-802. PubMed ID: 9300232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of postmeal exercise on postprandial glucose excursions in people with type 2 diabetes treated with add-on hypoglycemic agents.
    Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
    Diabetes Res Clin Pract; 2017 Apr; 126():240-247. PubMed ID: 28284168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross-over pilot study.
    Sato D; Morino K; Ogaku S; Tsuji A; Nishimura K; Sekine O; Ugi S; Maegawa H
    J Diabetes Investig; 2019 Sep; 10(5):1284-1290. PubMed ID: 30688410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
    Pilmark NS; Lyngbæk M; Oberholzer L; Elkjær I; Petersen-Bønding C; Kofoed K; Siebenmann C; Kellenberger K; van Hall G; Abildgaard J; Ellingsgaard H; Lauridsen C; Ried-Larsen M; Pedersen BK; Hansen KB; Karstoft K
    Diabetologia; 2021 Feb; 64(2):397-409. PubMed ID: 32979074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India.
    Krishnakumar S; Govindarajulu Y; Vishwanath U; Nagasubramanian VR; Palani T
    Diabetes Metab Syndr; 2020; 14(5):1379-1383. PubMed ID: 32755838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmeal exercise blunts postprandial glucose excursions in people on metformin monotherapy.
    Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
    J Appl Physiol (1985); 2017 Aug; 123(2):444-450. PubMed ID: 28522762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.
    Erle G; Lovise S; Stocchiero C; Lora L; Coppini A; Marchetti P; Merante D
    Acta Diabetol; 1999 Jun; 36(1-2):61-5. PubMed ID: 10436254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance.
    Ortega JF; Hamouti N; Fernández-Elías VE; de Prada MV; Martínez-Vizcaíno V; Mora-Rodríguez R
    Acta Diabetol; 2014 Oct; 51(5):749-55. PubMed ID: 24682492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes.
    Roach P; Malone JK
    Diabet Med; 2006 Jul; 23(7):743-9. PubMed ID: 16842478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring reveals different glycemic responses of moderate- vs high-carbohydrate lunch meals in people with type 2 diabetes.
    Powers MA; Cuddihy RM; Wesley D; Morgan B
    J Am Diet Assoc; 2010 Dec; 110(12):1912-5. PubMed ID: 21111100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-diabetic and diabetic adults.
    Moreno-Cabañas A; Morales-Palomo F; Alvarez-Jimenez L; Mora-Gonzalez D; Ortega JF; Mora-Rodriguez R
    Am J Physiol Endocrinol Metab; 2023 Oct; 325(4):E310-E324. PubMed ID: 37584610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.